MSBase: an international,online registry and platform for collaborative outcomes research in multiple sclerosis

Abstract

Observational cohort studies are a powerful tool to assess the long-term outcome in chronic diseases. This study design has been utilized in local and regional outcome studies in multiple sclerosis (MS) and has yielded invaluable epidemiological information. The World Wide Web now provides an excellent opportunity for an international, collaborative cohort study of MS outcomes. A web platform-MSBase-has been designed to collect prospective data on patients with MS. It is purely observational, enabling participating neurologists to contribute data on diagnosis, treatment and progress, to review anonymous aggregate data and to benchmark their patient population against other patient subsets or the entire dataset. MSBase facilitates collaborative research by allowing the online creation of investigator-initiated regional, national and international substudies. The registry aims to answer epidemiological questions that can only be addressed by prospective assessments of large patient cohorts. The registry is funded through the independent MSBase Foundation, and governed by an International Scientific Advisory Board. The MSBase Foundation commenced operations in July 2004 and since then, 22 neurologists from 11 countries have joined MSBase and are contributing 2400 patients to the total data pool.

Keywords

databasing international long-term multiple sclerosis online registry outcomes research

Get full access to this article

View all access options for this article.

References

Matthews WB. The symptoms and signs of MS. In Compston DAS et al. eds. McAlpine’s multiple sclerosis, third edition. Churchill Livingston , 1998: 145-190.

Confavreux C , Vukusic S , Moreau T , Adeleine P. Relapses and progression of disability in multiple sclerosis . N Engl J Med 2000; 343: 1430-1438 .

Australia’s Health 2000. The Seventh Biennial Health Report of the Australian Institute of Health and Welfare. AIHW , 2000.

O’Conner P , on behalf of the Canadian MS Working Group . Key issues in the diagnosis and treatment of multiple sclerosis: an overview . Neurology 2002; 59: 9-33 .

Wingerchuck DM , Noseworthy J. Randomized controlled trials to assess therapies for multiple sclerosis . Neurology 2002; 58: S40-S48 .

Weinshenker BG et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability . Brain 1989; 112: 133-146 .

Weinshenker BG. The natural history of multiple sclerosis . Neurol Clin 1995; 13: 119-146 .

Weinshenker B. Databases in MS research: pitfalls and promises . Mult Scler 1999; 5: 206-211 .

Benson K , Hartz AJ. A comparison of observational studies and randomized, controlled trials . N Engl J Med 2000; 342: 1878-1886 .

10.

Koch-Henriksen N , Rasmussen S , Stenager E , Madsen M. History, data collection and validity. The Danish Multiple Sclerosis Registry . Dan Med Bull 2001; 48: 91-94 .

11.

Celius EG , Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period . Eur J Neurol 2001; 8: 463-469 .

12.

Reports from the 2000 Annual Meetings of Rehabilitation in Multiple Sclerosis and the Consortium of Multiple Sclerosis Centers. Multiple sclerosis databases: stimulating research through international collaboration . Int J MS Care 2000; 2 (Suppl).

13.

Trojano M , Granieri E , Rosati G , Savettieri G , Comi G and the MSDN Study Group . The Multiple Sclerosis Database Network (MSDN): an Italian source of valuable data for clinical and research studies . J Neurol 2003; 250: 37-37 .

14.

Vollmer TL , Ni W , Stanton S , Hadjimichael O. The NARCOMS patient registry: a resource for investigators . Int J MS Care 1999; 1: 12-15 .

15.

Confavreux C , Paty DW. Current status of computerization of multiple sclerosis clinical data for research in Europe and North America: the EDMUS/MS-COSTAR connection . Neurology 1995; 45: 573-576 .

16.

Cottrell DA , Kremenchutzky M , Rice GPA , Koopman WJ , Hader W , Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. 5: The clinical features and natural history of primary progressive multiple sclerosis . Brain 1999; 122: 625-639 .

17.

Cottrell DA , Kremenchutzky M , Rice GPA , Koopman WJ , Hader W , Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. 6: Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis . Brain 1999; 122: 641-647 .

18.

Ebers G , Koopman WJ , Hader W , Sadovnick AD , Kremenchutzky M , Mandalfino P et al. The natural history of multiple sclerosis: a geographically based study. 8: Familial multiple sclerosis . Brain 2000; 123: 641-649 .

19.

Confavreux C , Saddier P , Grimaud J , Moreau T , Adeleine P , Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study . Neurology 1996; 46: 1607-1612 .

20.

Mechati S , Peyro-St-Paul H. iMed: a new electronic database for monitoring patients with multiple sclerosis . Mult Scler 2001; 7: S31-S31 .

21.

Wolinsky JS and the PROMise trial group . The PROMise trial: data review and progress report . Mult Scler 2004; 10: S65-S71 .